Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  European journal of medicinal chemistry

• Publication date

  2021-05-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2021.113581PMID 34102377PMCID PMC8373703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and function of adenylyl cyclases, key enzymes in cellular signaling.

  2020cited by this paper
• Selective Adenylyl Cyclase Type 1 Inhibitors as Potential Opioid Alternatives For Chronic Pain

  2018cited by this paper
• Nucleobase Modified Adefovir (PMEA) Analogues as Potent and Selective Inhibitors of Adenylate Cyclases from Bordetella pertussis and Bacillus anthracis

  2018cited by this paper
• Small molecule inhibitors of anthrax edema factor.

  2018cited by this paper
• Synthesis of α‐Branched Acyclic Nucleoside Phosphonates as Potential Inhibitors of Bacterial Adenylate Cyclases

  2018cited by this paper
• Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties

  2017cited by this paper
• Invasion of Dendritic Cells, Macrophages and Neutrophils by the Bordetella Adenylate Cyclase Toxin: A Subversive Move to Fool Host Immunity

  2017cited by this paper
• Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases

  2016cited by this paper
• Bisamidate Prodrugs of 2‐Substituted 9‐[2‐(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis

  2015cited by this paper
• Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

  2014cited by this paper
• Development of a High-Throughput Screening Paradigm for the Discovery of Small-Molecule Modulators of Adenylyl Cyclase: Identification of an Adenylyl Cyclase 2 Inhibitor

  2013cited by this paper
• Amidate Prodrugs of 9-[2-(Phosphonomethoxy)Ethyl]Adenine as Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis

  2013cited by this paper
• 2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.

  2013cited by this paper
• Isoform Selectivity of Adenylyl Cyclase Inhibitors: Characterization of Known and Novel Compounds

  2013cited by this paper
• Design, synthesis of some new (2-aminothiazol-4-yl)methylester derivatives as possible antimicrobial and antitubercular agents.

  2012cited by this paper
• Towards selective inhibitors of adenylyl cyclase toxin from Bordetella pertussis.

  2012cited by this paper
• Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38α.

  2012cited by this paper
• Inhibitors of membranous adenylyl cyclases.

  2012cited by this paper
• A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities.

  2011cited by this paper
• Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents.

  2011cited by this paper
• Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5′-triphosphates

  2011cited by this paper
• Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.

  2011cited by this paper
• The mechanism of the modified Ullmann reaction.

  2010cited by this paper
• The adenylyl cyclase activity of anthrax edema factor.

  2009cited by this paper
• Molecular Analysis of the Interaction of Anthrax Adenylyl Cyclase Toxin, Edema Factor, with 2′(3′)-O-(N-(methyl)anthraniloyl)-Substituted Purine and Pyrimidine Nucleotides

  2009cited by this paper
• Physiological Roles for G Protein-Regulated Adenylyl Cyclase Isoforms: Insights from Knockout and Overexpression Studies

  2008cited by this paper
• Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.

  2008cited by this paper
• Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.

  2007cited by this paper
• Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.

  2007cited by this paper
• Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation

  2006cited by this paper
• Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin

  2005cited by this paper
• MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes

  2005cited by this paper
• Differential Inhibition of Adenylyl Cyclase Isoforms and Soluble Guanylyl Cyclase by Purine and Pyrimidine Nucleotides*

  2004cited by this paper
• Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.

  2004cited by this paper
• The Adenylate Cyclase Toxins

  2004cited by this paper
• 2′(3′)-O-(N-Methylanthraniloyl)-substituted GTP Analogs: A Novel Class of Potent Competitive Adenylyl Cyclase Inhibitors*

  2003cited by this paper
• Regulation and role of adenylyl cyclase isoforms.

  2001cited by this paper
• Complexity and diversity of mammalian adenylyl cyclases.

  1996cited by this paper
• A novel selective broad-spectrum anti-DNA virus agent

  1986cited by this paper

• Benzyl-N-[4-(2-hydroxyethyl)-1,3-thiazol-2-yl]carbamate

  2025cites this paper
• Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications

  2025cites this paper
• Targeting virulence to disarm the pathogen: Enzyme-activated-substrate inhibition of Anthrax edema factor.

  2025cites this paper
• Stratifying macrophages based on their infectious burden identifies novel host targets for intervention during Crohn’s disease associated adherent-invasive Escherichia coli infection

  2024influential citation
• Biochemical pharmacology of adenylyl cyclases in cancer.

  2024cites this paper
• Harvesting phosphorus-containing moieties for their antibacterial effects.

  2023cites this paper
• Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects

  2022cites this paper
• Halogen‐Dance‐Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2‐Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases

  2021cites this paper
• Regioselective Pd-catalyzed α-alkylation of furans using alkyl iodides

  2021cites this paper